Jasper Therapeutics Inc. (JSPR) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-09
8:36 pm
Purchase
2024-02-0813DJasper Therapeutics, Inc.
JSPR
Velan Capital Investment Management LP1,471,903
9.800%
1,471,903increase
(New Position)
Filing
History
2024-02-05
09:15 am
Purchase
2023-12-3113GJasper Therapeutics, Inc.
JSPR
SPHERA FUNDS MANAGEMENT LTD.7,130,625
6.390%
6,561,912increase
(+1153.82%)
Filing
History
2024-02-02
09:50 am
Purchase
2023-12-3113GJasper Therapeutics, Inc.
JSPR
Soleus Capital Master Fund, L.P.987,096
8.800%
987,096increase
(New Position)
Filing
History
2023-10-10
11:15 am
Purchase
2023-09-2713GJasper Therapeutics, Inc.
JSPR
SPHERA FUNDS MANAGEMENT LTD.568,713
5.130%
568,713increase
(New Position)
Filing
History
2023-02-27
4:05 pm
Unchanged
2023-02-1613DJasper Therapeutics, Inc.
JSPR
Velan Capital Investment Management LP1,121,904
10.200%
0
(Unchanged)
Filing
History
2023-02-14
08:26 am
Purchase
2022-12-3113GJasper Therapeutics, Inc.
JSPR
Citadel Advisors LLC372,907
9.900%
4,787increase
(+1.30%)
Filing
History
2023-02-13
4:49 pm
Unchanged
2022-12-3113GJasper Therapeutics, Inc.
JSPR
Roche Finance Ltd462,461
4.200%
0
(Unchanged)
Filing
History
2023-02-10
4:18 pm
Sale
2023-01-3113GJasper Therapeutics, Inc.
JSPR
AMGEN INC
AMGN
100,993
0.900%
-169,007decrease
(-62.60%)
Filing
History
2023-02-06
4:43 pm
Purchase
2023-01-2513GJasper Therapeutics, Inc.
JSPR
BIOTECHNOLOGY VALUE FUND L P990,000
9.100%
990,000increase
(New Position)
Filing
History
2023-01-31
4:15 pm
Purchase
2023-01-2713DJasper Therapeutics, Inc.
JSPR
Carlyle Group Inc.
CG
876,189
8.000%
313,333increase
(+55.67%)
Filing
History
2023-01-30
5:01 pm
Purchase
2023-01-2713GJasper Therapeutics, Inc.
JSPR
Soleus Capital Master Fund, L.P.625,000
5.700%
625,000increase
(New Position)
Filing
History
2023-01-27
4:56 pm
Purchase
2023-01-2513GJasper Therapeutics, Inc.
JSPR
Velan Capital Investment Management LP1,121,904
10.200%
1,121,904increase
(New Position)
Filing
History
2022-08-11
4:47 pm
Purchase
2022-08-0113DJasper Therapeutics, Inc.
JSPR
Carlyle Group Inc.
CG
562,856
15.400%
562,856increase
(New Position)
Filing
History
2022-04-28
4:25 pm
Sale
2022-04-1213GJasper Therapeutics, Inc.
JSPR
Amplitude Healthcare Holdings LLC167,828
11.000%
-82,172decrease
(-32.87%)
Filing
History
2022-02-14
10:29 am
Unchanged
2021-12-3113GJasper Therapeutics, Inc.
JSPR
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)0
0.000%
0
(Unchanged)
Filing
History
2022-02-14
06:30 am
Sale
2021-12-3113GJasper Therapeutics, Inc.
JSPR
Citadel Advisors LLC368,120
9.900%
-186decrease
(-0.05%)
Filing
History
2022-02-11
5:02 pm
Unchanged
2021-12-3113GJasper Therapeutics, Inc.
JSPR
Beryl Capital Management LLC0
0.000%
0
(Unchanged)
Filing
History
2022-02-03
1:56 pm
Purchase
2021-12-3113GJasper Therapeutics, Inc.
JSPR
Tenor Capital Management Company, L.P.25,000
0.680%
25,000increase
(New Position)
Filing
History
2021-10-04
4:34 pm
Purchase
2020-09-2413GJasper Therapeutics, Inc.
JSPR
Amplitude Healthcare Holdings LLC250,000
6.850%
250,000increase
(New Position)
Filing
History
2021-10-04
4:10 pm
Purchase
2021-09-2413DJasper Therapeutics, Inc.
JSPR
Abingworth LLP562,856
15.400%
562,856increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, Next